CI 920

Known as: CI-920 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2009
01219832009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Fostriecin (CI-920) is a potent inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase 4(PP4) found to have… (More)
Is this relevant?
2003
2003
The total synthesis of an antitumor antibiotic, fostriecin (CI-920), via a highly convergent route is described. A characteristic… (More)
Is this relevant?
2002
2002
Fostriecin, a potent and promising antitumor antibiotic, was stereoselectively synthesized via a convergent route involving a… (More)
Is this relevant?
2001
2001
The first total synthesis of the potent antitumor agent fostriecin (CI-920) is described, confirming the relative and absolute… (More)
  • figure 1
Is this relevant?
1986
1986
The novel fermentation products fostriecin and analogs PD 113,270 and PD 113,271 are structurally related polyene lactone… (More)
Is this relevant?
1986
1986
A human tumor cloning assay was utilized to evaluate the antineoplastic activity of the novel antitumor antibiotic fostriecin (CI… (More)
Is this relevant?
1985
1985
CI-920 is a structurally novel, phosphate-containing polyene lactone antitumor agent isolated from a previously undescribed… (More)
Is this relevant?
1984
1984
Biochemical studies on a new antitumor antibiotic, CI-920, have been directed toward understanding its mode of action. The most… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1983
1983
A complex of structurally related compounds that exhibit in vivo antileukemic activity was isolated from fermentation broths of a… (More)
Is this relevant?
1983
1983
CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete… (More)
Is this relevant?